{
    "2018-03-26": [
        [
            {
                "time": "",
                "original_text": "销售费用大幅增加 华兰生物2017年净利同比增5.19%",
                "features": {
                    "keywords": [
                        "销售费用",
                        "华兰生物",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物：行业筑底中 增持评级",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "行业筑底",
                        "增持评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物：2017年净利润同比增5.19%，拟10派3元",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "净利润",
                        "同比增长",
                        "分红"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：深化审评审批改革卓有成效 资本助力创新发展",
                "features": {
                    "keywords": [
                        "医药生物",
                        "审评审批改革",
                        "资本助力",
                        "创新发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}